Skip to content
All news
Earnings

Sherwin-Williams Posts Strong Q1 2026 Sales Growth

Sherwin-Williams reported strong consolidated sales growth in the first quarter of 2026, with a low single-digit contribution from the Suvenil acquisition, amid heightened global uncertainty and persistent demand softness.

April 28, 2026
2 min read
Source: Motley Fool
Share:

Key Numbers

sales growth
high single-digit percentage
acquisition contribution
low single-digit percentage

The Sherwin-Williams Company (NYSE: SHW) announced robust financial results for the first quarter of 2026, with consolidated sales growing by a high single-digit percentage year-over-year, including a low single-digit contribution from the Suvenil acquisition. The earnings release, published today, highlighted the company's performance despite heightened global uncertainty and persistent demand softness in most end markets.

Key Financial Results

MetricQ1 2026
Consolidated Sales GrowthHigh single-digit (YoY)
Suvenil Acquisition ContributionLow single-digit

(The company did not disclose specific revenue, net income, or EPS figures in this release.)

Highlights from the Statement

Jim Jaye, Director of Investor Relations, noted that the company delivered strong sales despite macroeconomic headwinds, reflecting the resilience of its business model and brand strength. He also confirmed that the Suvenil acquisition contributed positively to the results.

Forward Guidance

No specific guidance for the next quarter or full fiscal year 2026 was provided in this release.

Impact on the Stock

Investors are likely to view these results favorably given the company's ability to grow in a challenging environment. However, attention will remain on overall demand trends and the impact of global uncertainty on the second half of the year.

What This Means for Investors

Sherwin-Williams' Q1 results demonstrate its capacity to achieve growth even under difficult market conditions. Investors are advised to monitor subsequent reports for more details on profitability and future guidance.

Frequently Asked Questions

The company reported high single-digit consolidated sales growth year-over-year, with a low single-digit contribution from the Suvenil acquisition.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.